Stem Cell Characterization and Analysis Tool Market Overview
Stem cell characterization is the study of tissue-specific differentiation. There are various techniques are used to characterized stem cells such as immunological techniques, used for the depiction of different populations of stem cells. The global Stem Cell Characterization and Analysis Tool market is projected to witness significant growth in the next few years.
The increasing chronic disorders such as cancer, diabetes, and others across the world is the prime factor to boost the growth of the stem cell characterization and analysis tools market. In addition, increasing awareness among people about the therapeutic potency of stem cells characterization in the management of effective diseases is projected to increase the demand for stem cell characterization and analysis tools. Eventually, it propelling the growth of the market.
Furthermore, there are various technologies such as flow cytometry which is used to characterize the cell surface profiling of human bone marrow and other related purposes are anticipated to upsurge the growth of stem cell characterization and analysis tools market. In addition to this, increasing investment by the private and public organization for research activities are expected to enhance the market growth in the coming years.
On the downside, the unclear guidelines and the technical limitation for the development of the product are likely to hamper the growth of the stem cell characterization and analysis tools market.
Covid-19 Impact on Stem Cell Characterization and Analysis Tool Market:
In addition, the current Stem Cell Characterization and Analysis Tool Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Stem Cell Characterization and Analysis Tool Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Stem Cell Characterization and Analysis Tool Market Segment Overview
Based on the Products and Service Type, the Human Embryonic Stem Cells segment is expected to dominate the market due to their indefinite life span and higher totipotency as compared to other stem cells. Additionally, based on the technology, the cell production segment is projected to increase the demand for stem cell characterization and analysis tools owing to their emerging applications for stem cells in drug testing in the management of effective diseases.
In terms of application, oncology is anticipated to show significant growth in the market. This is due to the increasing number of pipelines products for the treatment of cancers or tumors. Based on the end-user, pharmaceutical and biotechnology companies are anticipated to dominate the market due to rising global awareness about therapeutics research activities.
Stem Cell Characterization and Analysis Tool Market, By Products and Service Type
· Services
· Software’s
· Accessories
· Instruments
· Consumables
· Reagent and Assay Kits
· Microplates
· Other Consumables
· Adult Stem Cells (ASCs)
· Human Embryonic Stem Cells
· Induced Pluripotent Stem Cells
Stem Cell Characterization and Analysis Tool Market, By Technology
· Cell Acquisition
· Bone Marrow Harvest
· Umbilical Blood Cord
· Apheresis
· Cell Production
· Therapeutic Cloning
· In-vitro Fertilization
· Cell Culture
· Isolation
· Cryopreservation
· Expansion and Sub-Culture
Stem Cell Characterization and Analysis Tool Market, By Application
· Therapeutic Application
· Neurological Disorders
· Orthopedic Treatments
· Oncology Disorders
· Diabetes
· Other Therapeutic Applications
· Drug Development and Discovery Embryonic Stem Cells Research
Stem Cell Characterization and Analysis Tool Market, By End User
· Pharmaceutical and Biotechnology Companies
· Academic and Government Institutes
· Contract Research Organizations (CROs)
Stem Cell Characterization and Analysis Tool Market Regional Overview
Region-wise, North America is expected to rise at a significant pace during the forecast period. This is mainly due to growing cases of target chronic diseases and increasing investments for research activities in this region. Likewise, Europe is the second leading region to dominate the market. This can be attributed to the technological advancement and also surge in therapeutic activities, funded by governments across the globe. Similarly, the market in the Asia Pacific is projected to expand at a rapid growth rate during the forecast period. Factors such as increasing disposable income and growth in the development of infrastructure are contributing more to the development of the market in this region.
Stem Cell Characterization and Analysis Tool Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Stem Cell Characterization and Analysis Tool Market Competitor overview
Some key developments and strategies adopted by manufacturers in Stem Cell Characterization and Analysis Tool are highlighted below.
· In June 2021, NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the launch of the nCounter® Stem Cell Characterization Panel for the analysis and optimization of stem cell lines used in the development of potential novel therapeutics.
Stem Cell Characterization and Analysis Tool Market, Key Players
· Osiris Therapeutics, Inc.
· Caladrius Biosciences, Inc.
· U.S. Stem Cell, Inc.
· Astellas Pharma Inc.
· TEMCELL Technologies Inc.
· BioTime Inc.
· Cellular Engineering Technologies Inc.
· Cytori Therapeutics, Inc.
· BrainStorm Cell Therapeutics Inc.
Stem cell characterization is the study of tissue-specific differentiation. There are various techniques are used to characterized stem cells such as immunological techniques, used for the depiction of different populations of stem cells. The global Stem Cell Characterization and Analysis Tool market is projected to witness significant growth in the next few years.
The increasing chronic disorders such as cancer, diabetes, and others across the world is the prime factor to boost the growth of the stem cell characterization and analysis tools market. In addition, increasing awareness among people about the therapeutic potency of stem cells characterization in the management of effective diseases is projected to increase the demand for stem cell characterization and analysis tools. Eventually, it propelling the growth of the market.
Furthermore, there are various technologies such as flow cytometry which is used to characterize the cell surface profiling of human bone marrow and other related purposes are anticipated to upsurge the growth of stem cell characterization and analysis tools market. In addition to this, increasing investment by the private and public organization for research activities are expected to enhance the market growth in the coming years.
On the downside, the unclear guidelines and the technical limitation for the development of the product are likely to hamper the growth of the stem cell characterization and analysis tools market.
Covid-19 Impact on Stem Cell Characterization and Analysis Tool Market:
In addition, the current Stem Cell Characterization and Analysis Tool Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Stem Cell Characterization and Analysis Tool Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Stem Cell Characterization and Analysis Tool Market Segment Overview
Based on the Products and Service Type, the Human Embryonic Stem Cells segment is expected to dominate the market due to their indefinite life span and higher totipotency as compared to other stem cells. Additionally, based on the technology, the cell production segment is projected to increase the demand for stem cell characterization and analysis tools owing to their emerging applications for stem cells in drug testing in the management of effective diseases.
In terms of application, oncology is anticipated to show significant growth in the market. This is due to the increasing number of pipelines products for the treatment of cancers or tumors. Based on the end-user, pharmaceutical and biotechnology companies are anticipated to dominate the market due to rising global awareness about therapeutics research activities.
Stem Cell Characterization and Analysis Tool Market, By Products and Service Type
· Services
· Software’s
· Accessories
· Instruments
· Consumables
· Reagent and Assay Kits
· Microplates
· Other Consumables
· Adult Stem Cells (ASCs)
· Human Embryonic Stem Cells
· Induced Pluripotent Stem Cells
Stem Cell Characterization and Analysis Tool Market, By Technology
· Cell Acquisition
· Bone Marrow Harvest
· Umbilical Blood Cord
· Apheresis
· Cell Production
· Therapeutic Cloning
· In-vitro Fertilization
· Cell Culture
· Isolation
· Cryopreservation
· Expansion and Sub-Culture
Stem Cell Characterization and Analysis Tool Market, By Application
· Therapeutic Application
· Neurological Disorders
· Orthopedic Treatments
· Oncology Disorders
· Diabetes
· Other Therapeutic Applications
· Drug Development and Discovery Embryonic Stem Cells Research
Stem Cell Characterization and Analysis Tool Market, By End User
· Pharmaceutical and Biotechnology Companies
· Academic and Government Institutes
· Contract Research Organizations (CROs)
Stem Cell Characterization and Analysis Tool Market Regional Overview
Region-wise, North America is expected to rise at a significant pace during the forecast period. This is mainly due to growing cases of target chronic diseases and increasing investments for research activities in this region. Likewise, Europe is the second leading region to dominate the market. This can be attributed to the technological advancement and also surge in therapeutic activities, funded by governments across the globe. Similarly, the market in the Asia Pacific is projected to expand at a rapid growth rate during the forecast period. Factors such as increasing disposable income and growth in the development of infrastructure are contributing more to the development of the market in this region.
Stem Cell Characterization and Analysis Tool Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Stem Cell Characterization and Analysis Tool Market Competitor overview
Some key developments and strategies adopted by manufacturers in Stem Cell Characterization and Analysis Tool are highlighted below.
· In June 2021, NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the launch of the nCounter® Stem Cell Characterization Panel for the analysis and optimization of stem cell lines used in the development of potential novel therapeutics.
Stem Cell Characterization and Analysis Tool Market, Key Players
· Osiris Therapeutics, Inc.
· Caladrius Biosciences, Inc.
· U.S. Stem Cell, Inc.
· Astellas Pharma Inc.
· TEMCELL Technologies Inc.
· BioTime Inc.
· Cellular Engineering Technologies Inc.
· Cytori Therapeutics, Inc.
· BrainStorm Cell Therapeutics Inc.
Stem Cell Characterization and Analysis Tool Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Stem Cell Characterization and Analysis Tool Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Products and Service Type
- 5.2.1. Services
- 5.2.2. Software’s
- 5.2.3. Accessories
- 5.2.4. Instruments
- 5.2.5. Consumables
- 5.2.6. Reagent and Assay Kits
- 5.2.7. Microplates
- 5.2.8. Other Consumables
- 5.2.9. Adult Stem Cells (ASCs)
- 5.2.10. Human Embryonic Stem Cells
- 5.2.11. Induced Pluripotent Stem Cells
- 5.3. Market Analysis, Insights and Forecast – By Technology
- 5.3.1. Cell Acquisition
- 5.3.2. Bone Marrow Harvest
- 5.3.3. Umbilical Blood Cord
- 5.3.4. Apheresis
- 5.3.5. Cell Production
- 5.3.6. Therapeutic Cloning
- 5.3.7. In-vitro Fertilization
- 5.3.8. Cell Culture
- 5.3.9. Isolation
- 5.3.10. Cryopreservation
- 5.3.11. Expansion and Sub-Culture
- 5.4. Market Analysis, Insights and Forecast – By Application
- 5.4.1. Therapeutic Application
- 5.4.2. Neurological Disorders
- 5.4.3. Orthopedic Treatments
- 5.4.4. Oncology Disorders
- 5.4.5. Diabetes
- 5.4.6. Other Therapeutic Applications
- 5.4.7. Drug Development and Discovery Embryonic Stem Cells Research
- 5.5. Market Analysis, Insights and Forecast – By End User
- 5.5.1. Pharmaceutical and Biotechnology Companies
- 5.5.2. Academic and Government Institutes
- 5.5.3. Contract Research Organizations (CROs)
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America, Middle East and Africa
6. North America Stem Cell Characterization and Analysis Tool Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Products and Service Type
- 6.2.1. Services
- 6.2.2. Software’s
- 6.2.3. Accessories
- 6.2.4. Instruments
- 6.2.5. Consumables
- 6.2.6. Reagent and Assay Kits
- 6.2.7. Microplates
- 6.2.8. Other Consumables
- 6.2.9. Adult Stem Cells (ASCs)
- 6.2.10. Human Embryonic Stem Cells
- 6.2.11. Induced Pluripotent Stem Cells
- 6.3. Market Analysis, Insights and Forecast – By Technology
- 6.3.1. Cell Acquisition
- 6.3.2. Bone Marrow Harvest
- 6.3.3. Umbilical Blood Cord
- 6.3.4. Apheresis
- 6.3.5. Cell Production
- 6.3.6. Therapeutic Cloning
- 6.3.7. In-vitro Fertilization
- 6.3.8. Cell Culture
- 6.3.9. Isolation
- 6.3.10. Cryopreservation
- 6.3.11. Expansion and Sub-Culture
- 6.4. Market Analysis, Insights and Forecast – By Application
- 6.4.1. Therapeutic Application
- 6.4.2. Neurological Disorders
- 6.4.3. Orthopedic Treatments
- 6.4.4. Oncology Disorders
- 6.4.5. Diabetes
- 6.4.6. Other Therapeutic Applications
- 6.4.7. Drug Development and Discovery Embryonic Stem Cells Research
- 6.5. Market Analysis, Insights and Forecast – By End User
- 6.5.1. Pharmaceutical and Biotechnology Companies
- 6.5.2. Academic and Government Institutes
- 6.5.3. Contract Research Organizations (CROs)
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe Stem Cell Characterization and Analysis Tool Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Products and Service Type
- 7.2.1. Services
- 7.2.2. Software’s
- 7.2.3. Accessories
- 7.2.4. Instruments
- 7.2.5. Consumables
- 7.2.6. Reagent and Assay Kits
- 7.2.7. Microplates
- 7.2.8. Other Consumables
- 7.2.9. Adult Stem Cells (ASCs)
- 7.2.10. Human Embryonic Stem Cells
- 7.2.11. Induced Pluripotent Stem Cells
- 7.3. Market Analysis, Insights and Forecast – By Technology
- 7.3.1. Cell Acquisition
- 7.3.2. Bone Marrow Harvest
- 7.3.3. Umbilical Blood Cord
- 7.3.4. Apheresis
- 7.3.5. Cell Production
- 7.3.6. Therapeutic Cloning
- 7.3.7. In-vitro Fertilization
- 7.3.8. Cell Culture
- 7.3.9. Isolation
- 7.3.10. Cryopreservation
- 7.3.11. Expansion and Sub-Culture
- 7.4. Market Analysis, Insights and Forecast – By Application
- 7.4.1. Therapeutic Application
- 7.4.2. Neurological Disorders
- 7.4.3. Orthopedic Treatments
- 7.4.4. Oncology Disorders
- 7.4.5. Diabetes
- 7.4.6. Other Therapeutic Applications
- 7.4.7. Drug Development and Discovery Embryonic Stem Cells Research
- 7.5. Market Analysis, Insights and Forecast – By End User
- 7.5.1. Pharmaceutical and Biotechnology Companies
- 7.5.2. Academic and Government Institutes
- 7.6. Contract Research Organizations (CROs)
- 7.7. Market Analysis, Insights and Forecast – By Country
- 7.7.1. UK
- 7.7.2. Germany
- 7.7.3. France
- 7.7.4. Italy
- 7.7.5. Spain
- 7.7.6. Russia
- 7.7.7. Rest of Europe
8. Asia Pacific Stem Cell Characterization and Analysis Tool Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Products and Service Type
- 8.2.1. Services
- 8.2.2. Software’s
- 8.2.3. Accessories
- 8.2.4. Instruments
- 8.2.5. Consumables
- 8.2.6. Reagent and Assay Kits
- 8.2.7. Microplates
- 8.2.8. Other Consumables
- 8.2.9. Adult Stem Cells (ASCs)
- 8.2.10. Human Embryonic Stem Cells
- 8.2.11. Induced Pluripotent Stem Cells
- 8.3. Market Analysis, Insights and Forecast – By Technology
- 8.3.1. Cell Acquisition
- 8.3.2. Bone Marrow Harvest
- 8.3.3. Umbilical Blood Cord
- 8.3.4. Apheresis
- 8.3.5. Cell Production
- 8.3.6. Therapeutic Cloning
- 8.3.7. In-vitro Fertilization
- 8.3.8. Cell Culture
- 8.3.9. Isolation
- 8.3.10. Cryopreservation
- 8.3.11. Expansion and Sub-Culture
- 8.4. Market Analysis, Insights and Forecast – By Application
- 8.4.1. Therapeutic Application
- 8.4.2. Neurological Disorders
- 8.4.3. Orthopedic Treatments
- 8.4.4. Oncology Disorders
- 8.4.5. Diabetes
- 8.4.6. Other Therapeutic Applications
- 8.4.7. Drug Development and Discovery Embryonic Stem Cells Research
- 8.5. Market Analysis, Insights and Forecast – By End User
- 8.5.1. Pharmaceutical and Biotechnology Companies
- 8.5.2. Academic and Government Institutes
- 8.6. Contract Research Organizations (CROs)
- 8.7. Market Analysis, Insights and Forecast – By Country
- 8.7.1. China
- 8.7.2. India
- 8.7.3. Japan
- 8.7.4. Australia
- 8.7.5. South East Asia
- 8.7.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Stem Cell Characterization and Analysis Tool Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Products and Service Type
- 9.2.1. Services
- 9.2.2. Software’s
- 9.2.3. Accessories
- 9.2.4. Instruments
- 9.2.5. Consumables
- 9.2.6. Reagent and Assay Kits
- 9.2.7. Microplates
- 9.2.8. Other Consumables
- 9.2.9. Adult Stem Cells (ASCs)
- 9.2.10. Human Embryonic Stem Cells
- 9.2.11. Induced Pluripotent Stem Cells
- 9.3. Market Analysis, Insights and Forecast – By Technology
- 9.3.1. Cell Acquisition
- 9.3.2. Bone Marrow Harvest
- 9.3.3. Umbilical Blood Cord
- 9.3.4. Apheresis
- 9.3.5. Cell Production
- 9.3.6. Therapeutic Cloning
- 9.3.7. In-vitro Fertilization
- 9.3.8. Cell Culture
- 9.3.9. Isolation
- 9.3.10. Cryopreservation
- 9.3.11. Expansion and Sub-Culture
- 9.4. Market Analysis, Insights and Forecast – By Application
- 9.4.1. Therapeutic Application
- 9.4.2. Neurological Disorders
- 9.4.3. Orthopedic Treatments
- 9.4.4. Oncology Disorders
- 9.4.5. Diabetes
- 9.4.6. Other Therapeutic Applications
- 9.4.7. Drug Development and Discovery Embryonic Stem Cells Research
- 9.5. Market Analysis, Insights and Forecast – By End User
- 9.5.1. Pharmaceutical and Biotechnology Companies
- 9.5.2. Academic and Government Institutes
- 9.5.3. Contract Research Organizations (CROs)
- 9.6. Market Analysis, Insights and Forecast – By Country
- 9.6.1. Brazil
- 9.6.2. Saudi Arabia
- 9.6.3. UAE
- 9.6.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Osiris Therapeutics, Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Petronas
- 10.6. Caladrius Biosciences, Inc.
- 10.7. U.S. Stem Cell, Inc.
- 10.8. Astellas Pharma Inc.
- 10.9. TEMCELL Technologies Inc.
- 10.10. BioTime Inc.
- 10.11. Cellular Engineering Technologies Inc.
- 10.12. Cytori Therapeutics, Inc.
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
